Department of Orthopaedic Surgery, University of Edinburgh, Edinburgh, UK.
Department of Radiology, Royal Infirmary of Edinburgh, Edinburgh, UK.
Bone Joint J. 2020 May;102-B(5):606-610. doi: 10.1302/0301-620X.102B5.BJJ-2020-0082.
The primary aim of this study was to evaluate the efficacy of distension arthrography in the treatment of adhesive capsulitis of the shoulder. The secondary aim was to assess which patient and procedural factors predicted the recurrence of symptoms after the procedure.
All patients referred to our shoulder clinic over a ten-year period, between 2008 and 2018, with a clinical diagnosis of capsulitis and symptoms persisting for more than six months, were offered treatment with a distension arthrogram. All procedures were performed by one of five musculoskeletal radiologists, with a combination of steroid, local anaesthetic, and a distention volume of 10 ml, 30 ml, or 50 ml. Patient demographics, procedural details, recurrence of symptoms, and the need for further intervention were evaluated.
A total of 2,432 distension arthrograms were performed during the study period. The mean time between arthrography and analysis was 5.4 years (SD 4.4; 1 to 11). Recurrent symptoms occurred in 184 cases (7.6%), all of whom had a repeat distension arthrogram at a median of nine months (interquartile range (IQR) 6.0 to 15.3). The requirement for further intervention for persistent symptoms following arthrography was significantly associated with diabetes (p < 0.001) and bilateral capsulitis (p < 0.001). The volume of distension, either with air or saline, showed a dose-dependent advantage. Distension of 50 ml versus 30 ml showed a significantly decreased odds ratio for recurrence of 2.2 (95% confidence interval (CI) 1.6 to 3.0; p < 0.001). Capsule rupture (p = 0.615) or steroid dose (p = 0.275) did not significantly affect the rate of recurrence. There were no infections or neurovascular injuries. Following the second distension arthrogram, the symptoms resolved in 137 cases (74.5%) with no further intervention being required. An arthroscopic capsular release was ultimately required in 41 cases, comprising 1.7% of the entire cohort.
We found a low rate of repeat intervention following distension arthrography in patients with adhesive capsulitis of the shoulder, at long term follow-up. Greater volumes of distension are associated with lower rates of recurrence independent of capsule rupture. Cite this article: 2020;102-B(5):606-610.
本研究的主要目的是评估肩关节粘连性囊炎的扩张关节造影术的疗效。次要目的是评估哪些患者和程序因素可预测术后症状复发。
在 2008 年至 2018 年的十年间,我们向所有因肩部囊膜炎且症状持续超过六个月而到我们肩部诊所就诊的患者提供扩张关节造影术治疗。所有程序均由五名肌肉骨骼放射科医生之一进行,使用类固醇、局部麻醉剂和 10 毫升、30 毫升或 50 毫升的扩张量。评估患者人口统计学资料、程序细节、症状复发和进一步干预的需求。
在研究期间共进行了 2432 次扩张关节造影术。关节造影术后和分析之间的平均时间为 5.4 年(标准差 4.4;1 至 11)。184 例(7.6%)出现复发性症状,所有患者均在中位数为 9 个月(四分位距(IQR)6.0 至 15.3)时接受了重复扩张关节造影术。关节造影术后持续性症状进一步干预的需求与糖尿病(p<0.001)和双侧囊膜炎(p<0.001)显著相关。空气或盐水扩张的体积呈剂量依赖性优势。与 30 毫升相比,50 毫升的扩张显著降低了 2.2 的复发比值比(95%置信区间(CI)1.6 至 3.0;p<0.001)。囊破裂(p=0.615)或类固醇剂量(p=0.275)并未显著影响复发率。没有感染或神经血管损伤。在第二次扩张关节造影术后,137 例(74.5%)症状缓解,无需进一步干预。最终有 41 例患者需要关节镜下囊松解术,占整个队列的 1.7%。
我们发现,在肩关节粘连性囊炎患者中,扩张关节造影术后的再次干预率较低,长期随访结果如此。更大的扩张量与独立于囊破裂的更低复发率相关。